GATEWAY IS NOW ACTIVELY ENROLLING AT 3 US CLINICAL SITES!
#GATEWAY is a Vivet Therapeutics clinical trial for #WilsonDisease, taking place at several clinical sites across the United States and Europe.
Learn more about this currently recruiting clinical trial and our #Gene Therapy, VTX-801:
February 2022 Update
Share This Story, Choose Your Platform!